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Hepatitis C virus (HCV) core protein has many intriguing properties and plays an important role in cell growth regulation.
We have recently shown that the HCV core protein from genotype 1a promotes primary human hepatocytes to an
immortalized phenotype. Here, we investigated whether the presence of core protein is necessary for maintenance of the
immortalized hepatocytes and investigated its consequences on cellular gene expression. The introduction of an antisense
orientation of the core gene into immortalized hepatocytes led to the onset of cell death. Further analysis suggested that cell
death occurred through apoptosis associated with the activation of tumor suppressor pathways. Antisense core gene
expression in immortalized hepatocytes increased p53 expression at both the mRNA and the protein levels. A decreased
telomere length and reduced c-myc protein expression were also observed in hepatocytes when the antisense core gene
was introduced. Results from these studies suggested that modulation of cell cycle regulatory genes by repression of core
protein expression is responsible for reversion of the immortalized phenotype of the hepatocytes. Thus, targeted inhibitionINTRODUCTION
Hepatitis C virus (HCV) often causes a prolonged and
persistent infection, and an association between hepa-
tocellular carcinoma and HCV infection has been noted
(Saito et al., 1990; Alter, 1995; Idilman et al., 1998; Koike
et al., 2000). Hepatocellular carcinogenesis is a multistep
process and thus makes it difficult to understand the
precise mechanism of immortalization and transforma-
tion at the cellular level. We and others have identified a
number of important functional properties of the HCV
core protein. These include a trans-regulatory role of
several cellular promoters and regulation of cell growth
(Lai and Ware, 2000; McLauchlan, 2000; Choi et al., 2001;
Ray and Ray, 2001). Overproduction and release of non-
enveloped HCV nucleocapsids into the bloodstream of
an infected host and accumulation of core protein in liver
cells of infected chimpanzees in the acute phase of
infection have been demonstrated (Maillard et al., 2001).
Accumulation of the core particles may be an unconven-
tional means by which HCV may impose restrictions on
its natural host for viral persistence. Hepatic steatosis
occurs at a high rate in chronic hepatitis C patients, even
in those with cirrhosis, and a close relationship between
1 To whom correspondence and reprint requests should be ad-
dressed at Division of Infectious Diseases and Immunology, Saint53steatosis and intrahepatic core protein expression has
been noted (Fujie et al., 1999).
We have recently observed that the HCV core protein
promotes primary human hepatocytes, a natural host for
virus replication and tropism, to an immortalized pheno-
type (Ray et al., 2000). Cells that retained an immortalized
phenotype displayed a weak level of core protein expres-
sion and exhibited continuous growth for more than 3
years. Reactivation of telomerase was observed in HCV
core protein mediated immortalized hepatocytes. The
present study was designed to examine whether the
suppression of core gene expression has an effect upon
the maintenance of immortalized hepatocytes and if
there are any corresponding consequences on cellular
gene expression. Antisense RNA is a major strategy for
the downregulation of protein expression and can be
approached by the use of a synthetic oligonucleotide or
plasmid construct expressing antisense RNA within the
cell. The major advantage of using a plasmid construct is
the generation of a large quantity of antisense RNA
within the cells; also delivery of plasmid DNA is more
efficient and specific than the delivery of oligonucleotide
(He and Huang, 1997). Here, we have used an antisense
orientation of the core gene cloned under the control of
an inducible metallothionein promoter for introduction
into HCV core mediated immortalized human hepato-
cytes. We observed that repression of the core genemay contribute to the development of new therapeutic mod
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apoptosis and characteristic changes in p53, c-myc, and
hTERT expression.
RESULTS
Inhibition of HCV core protein expression induces cell
death
Primary human hepatocytes immortalized by the HCV
core gene were used in this study. Immortalized hepato-
cytes expressing an antisense core (AS-core) gene from
an inducible metallothionein promoter by treatment with
a predetermined dose of ZnCl2 (100 M) displayed a
decrease in cell viability after 6 days and massive cell
death between 7 and 10 days (Fig. 1). In contrast, empty
vector transfected hepatocytes, treated similarly with
ZnCl2, exhibited a growth pattern like that observed with
untransfected cells treated with the same predetermined
dose of ZnCl2. We also used constitutive expression of
the antisense core gene, cloned under the control of
MuLV LTR promoter in pBabe-puro vector, to study the
growth properties of immortalized hepatocytes when
core protein expression has been suppressed. Primary
human hepatocytes immortalized by introduction of the
core gene cloned under the control of the CMV promoter
in the pcDNA3 expression vector (Ray et al., 2000) were
transfected with the antisense core gene cloned in
pBabe-puro vector. Transfected hepatocytes after 4 days
of puromycin selection grew for a very short period of
time (3–5 days), after which hepatocytes died. On the
other hand, mock transfected hepatocytes steadily grew
under parallel culture conditions after puromycin selec-
tion. This result is in agreement with our AS-core gene
expression under the inducible promoter and consistent
observations were noted from at least four different ex-
periments. A nonneoplastic human hepatocyte cell line
(THLE5B) generated by transfection of primary human
liver epithelial cells with SV40 T antigen (Pfeifer et al.,
1993) was also used as a negative control. Transfection
of the AS-core gene into THLE5B did not display any
detectable change in growth characteristics. Introduc-
tion of antisense orientation of an unrelated protein
(MIP2A) as an additional negative control also did not
alter immortalized hepatocyte growth. Results from these
different expression systems suggested that antisense
core gene expression alters the survival of the HCV core
induced immortalized hepatocytes.
Inhibition of HCV core protein expression by
antisense core gene
Immortalized human hepatocytes transfected with the
AS-core gene cloned under the control of a metallothio-
nein promoter or empty vector were induced with ZnCl2
(100 M). Cells were harvested after induction for
Western blot analysis to determine the level of core
protein inhibition. Western blot analysis suggested a
weak level of core protein expression in empty vector
transfected immortalized hepatocytes, which decreased
60% in AS-core gene transfected hepatocytes on day 2
and remained at a similar level on day 4 and day 6 (Fig.
2A), as determined by densitometric scanning. FACS
analysis suggested an 72% reduction in median fluo-
rescence intensity upon AS-core gene expression in
hepatocytes following induction with ZnCl2 as compared
to uninduced hepatocyte controls (Fig. 2B). Together, our
results suggest that antisense core gene expression
decreases core protein to a significant level in immortal-
ized human hepatocytes.
Introduction of antisense core gene results in
apoptotic cell death
To determine whether the observed hepatocyte death
was associated with apoptosis, both mock and AS-core
gene transfected hepatocyte cultures were induced by
ZnCl2. Cells were harvested between 6 and 7 days and
examined for a characteristic DNA ladder for apoptosis.
DNA from AS-core gene expressing hepatocytes dis-
played apoptotic signature oligonucleosome fragments
by agarose gel electrophoresis (Fig. 3A). On the other
hand, cells transfected with an empty vector control DNA
did not display the characteristic DNA ladder. The level
of apoptosis in hepatocytes was also quantified by Cell
Death Detection ELISA (Roche), which is based on the
quantitative sandwich-immunoassay principle using
mouse monoclonal antibodies against DNA and histone.
Analysis of the AS-core transfected hepatocytes sug-
gested a significant level of apoptotic cell death as com-
pared to the hepatocytes transfected with vector control
(Fig. 3B). Together, these results indicated that the intro-
duction of the AS-core gene induces apoptosis in hepa-
tocytes immortalized by HCV core protein.
FIG. 1. Effect of antisense core gene expression under the control of
a metallothionein promoter on the growth of immortalized human hepa-
tocytes (squares). Untransfected (circles) or vector-transfected control
cells (triangles) were similarly treated for comparison. Cells were
plated in triplicate wells and induced with a predetermined dose of
ZnCl2 (100 M). Cell viability was counted by trypan blue exclusion at
different time points and is presented as mean values.
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Antisense core gene alters cellular gene expression
Primary culture of human cells must overcome the first
barrier to cellular proliferation, referred to as senes-
cence, which minimally involves the p53 and Rb tumor-
suppressor pathways (Stewart and Weinberg, 2000). p21
can be transcriptionally regulated by the p53 tumor sup-
pressor protein and is thus believed to participate in the
execution of p53 effects. Induction of p21 can also be
mediated via p53-independent pathways. We have pre-
viously reported from in vitro transient transfection stud-
ies that core protein transcriptionally regulates a number
of cellular promoters, including p53 and p21 (Ray et al.,
1997, 1998a). Results from our mutational analysis sug-
gested that the core protein responsive element in the
p21 promoter is located downstream of the p53-binding
site. These data suggested an independent effect of the
core protein on p53 and p21 promoters. Here, we exam-
ined whether core protein alters the endogenous expres-
sion of p53 and p21 genes following induction of the
AS-core gene expression by ZnCl2 in immortalized hu-
man hepatocytes. After induction of AS-core gene ex-
pression, cells were examined for p53 and p21 RNA
levels. The p53 mRNA expression level was upregulated
(approximately twofold) in AS-core expressing cells,
when compared with the vector control (Figs. 4A and 4B).
On the other hand, p21 mRNA level decreased (40%) in
AS-core expressing cells, as compared to the vector
transfected control cells. The protein expression levels of
p53 and p21 following AS-core gene expression were
also determined by Western blot analysis. Results sug-
FIG. 2. (A) Western blot analysis for core protein expression in
immortalized hepatocytes transfected with the empty vector or AS-core
gene under the control of a metallothionein promoter. Core protein
expression in empty vector control (lane 1) and AS-core expressing
hepatocytes after induction with ZnCl2 on day 2 (lane 2), day 4 (lane 3),
and day 6 (lane 4) is shown. Molecular weight of the core protein (22
kDa) was ascertained from positions of prestained molecular weight
markers (Gibco BRL) and is indicated by an arrow on the right. The blot
was reprobed with an antibody to actin as an internal control. (B)
FACScan analysis of core protein expression in antisense core gene
expressing immortalized hepatocytes. The antisense core gene was
under the control of metallothionein promoter. Core protein expression
levels in uninduced (thick black line), ZnCl2-induced (sharp black line)
cells and background binding measured as reagent control (light gray
line) are shown. The histograms showing the core protein expression
level were measured by fluorescence-emitting FITC stained cells.
FIG. 3. (A) Analysis of DNA fragmentation in empty vector and
antisense core gene expressing hepatocytes. DNA extracted from the
hepatocytes was analyzed by 1.6% agarose gel electrophoresis. The
X174-HaeIII digest was used as a marker. (B) Quantitation of apoptotic
cell death in vector control and AS-core-expressing immortalized hepa-
tocytes. DNA fragmentation was measured by quantitation of cytosolic
oligonucleosome-bound DNA using ELISA (Roche).
FIG. 4. (A) The mRNA expression levels of p53 and p21 in empty
vector and AS-core gene expressing human hepatocytes by RNase
protection assay. The protected fragments were analyzed by urea–
PAGE, followed by autoradiography. The housekeeping gene L32 was
used as a control. (B) Relative abundance of p53 and p21 mRNAs was
estimated by densitometric scanning of the autoradiogram after nor-
malization against L-32 and is shown as a bar diagram.
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gested an 3 times higher level of p53 expression in
AS-core expressing cells, as compared to vector trans-
fected control cells (Fig. 5A), supporting the RNase pro-
tection assay result. On the other hand, a slightly lower
level of p21 protein expression was observed in AS-core
expressing cells as compared to vector transfected con-
trol cells. We also examined the Rb protein expression
level, and our results did not suggest a detectable alter-
ation when compared to vector transfected control cells.
p53 induces apoptotic cell death involving mitochon-
dria, eventually activating procaspase-9 (Marchenko et
al., 2000). Since we observed an increased p53 expres-
sion and apoptotic cell death following expression of the
AS-core gene, we determined the status of initiator pro-
caspase-9, a downstream target of p53 (Iordanov et al.,
2000) by Western blot analysis. Procaspase-9 is cleaved
to its active polypeptides of 35 and 10 kDa upon activa-
tion. The antibody used in Western blot analysis recog-
nizes the 48-kDa band of procaspase-9. A significant
decrease of procaspase-9 was observed in AS-core ex-
pressing hepatocytes, as compared to vector control
cells (Fig. 5B). The blot was reprobed with an antibody to
actin and exhibited the presence of a similar amount of
protein load in each lane. Thus, inhibition of HCV core
protein expression appears to activate procaspase-9 of
the apoptotic pathway.
Telomerase activity is decreased by antisense core
gene expression
Telomerase is a ribonucleoprotein that synthesizes
telomeric DNA repeats onto the ends of chromosomes.
The telomerase reaction is considered to be a critical
step in allowing cells to escape from senescence and
proliferate. Either oncogene activation or a loss of tumor
suppressor function is the probable mechanism by
which activation of the telomerase reverse transcriptase
occurs. We previously observed that telomerase is reac-
tivated in core protein-immortalized human hepatocytes
immediately after senescence (Ray et al., 2000). Here, we
examined whether telomerase activity is altered in hepa-
tocytes after expression of the antisense core gene by
TRAP assay. Human cervical carcinoma (HeLa) cells and
human foreskin fibroblasts (HFF) were used as positive
and negative controls, respectively. The telomere length
(ladder formation) was elongated in the vector trans-
fected control cells as compared to the AS-core express-
ing cells (Fig. 6A). These results suggested that cells
expressing the antisense orientation of the core gene
exhibited a reduction in telomerase activity. The short-
ened telomere formed over the course of cell division
may be initiating DNA damage through p53-dependent
checkpoints, which are reflected by the difference in
growth properties of control and experimental hepato-
cytes.
Since AS-core gene expression reduces telomerase
activity, we examined whether the core protein has a role
in transcription modulation of hTERT promoter activity.
An in vitro transient reporter assay using HepG2 and 293
cells was performed. Cells were cotransfected with a
luciferase reporter construct having 800 bp of se-
quence upstream from the translation start site of the
hTERT gene (hTERT-Luc), HCV core, and/or AS-core us-
FIG. 5. (A) Expression level of p53, p21, and Rb proteins in empty vector control or AS-core expressing hepatocytes. Cell lysates were subjected
to Western blot analysis using specific antibodies. The level of cellular actin was used as an internal control for comparison. Arrows on the right
indicate respective proteins. Molecular weights were ascertained from the positions of a prestained molecular weight marker (Gibco BRL). (B)
Inhibition of core protein expression induces activation of procaspase-9. Cell lysates were prepared after induction with ZnCl2 and analyzed for
procaspase-9 by Western blot using a specific antibody. The blot was reprobed with an antibody to actin for normalization.
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ing lipofectamine. Analysis of luciferase activity in the
cell lysates suggested that HCV core protein upregulates
hTERT promoter activity in the HepG2 cells (Fig. 6B). On
the other hand, cotransfection of cells with both the core
and AS-core gene decreased hTERT promoter activity at
the basal level. However, the AS-core gene did not have
a detectable effect on hTERT promoter activity. Upregu-
lation of hTERT promoter activity by core protein was
also observed in 293 cells at a much higher magnitude
(approximately eightfold), as compared to HepG2 cells
(figure not shown), and may be responsible for a differ-
ence in transfection efficiency. These results suggest
that core protein upregulates hTERT activity, which in
turn may play a role in the immortalization of normal
human hepatocytes.
We observed previously that HCV core protein upregu-
lates c-myc promoter activity (Ray et al., 1995). c-myc is
known to enhance hTERT gene activity at the transcrip-
tional level (Wu et al., 1999; Wang et al., 2000). To exam-
ine whether introduction of the antisense core gene
influences c-myc protein expression level, Western blot
analysis was performed using cell lysates and a c-myc-
specific antibody. Our results suggested that expression
of AS-core reduces c-myc protein approximately three-
fold, when compared to vector transfected control cells
(Fig. 6C).
DISCUSSION
Primary human hepatocytes have a short life span in
culture. Introduction of the HCV core gene immortalizes
primary human hepatocytes at a frequency of 1.0–1.5 
104. An associated increase in telomerase elongation in
these immortalized cells was observed from our earlier
FIG. 6. (A) Telomerase activity in empty vector control and AS-core gene expressing hepatocytes was examined by TRAP assay. HeLa and HFF
cells were used as positive and negative controls, respectively. (B) Transcriptional regulation of the hTERT promoter by HCV core protein in a transient
transfection assay. A hTERT-luciferase reporter gene was cotransfected with HCV core and/or with the AS-core gene into HepG2 cells. Cell extracts
were prepared after 48 h of transfection and analyzed for luciferase activity. Results are shown as the fold difference of luciferase activity in cells.
(C) Western blot analysis for c-myc expression in vector control and antisense core gene expressing hepatocytes. The blot was reprobed with an
antibody to actin.
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study (Ray et al., 2000). Here, we investigated whether
the presence of core protein is necessary for the main-
tenance of the immortalized human hepatocytes. Expres-
sion of an antisense orientation of the core gene into
immortalized hepatocytes led to the onset of cell death.
Interestingly, a time lag from the onset of antisense core
gene expression and cell death was observed. However,
the reason for this time lag is unknown. A similar lag
period in cell death was observed following expression
of the antisense E7 gene in HeLa cells containing human
papilloma virus type 18 DNA (Steele et al., 1992).
The factors that affect the efficacy of the antisense
molecule are largely unknown. Earlier studies using the
antisense method also suggested a reduction, rather
than a complete shutdown, of the target protein (He and
Huang, 1997; Wakita et al., 1999; Nakamura et al., 2000).
The effect of antisense RNA depends on the host chro-
mosomal site of transfected DNA integration, level of
expression, and its stability within the cell. Most impor-
tantly, the concentration of the antisense RNA within the
cells needs to be sufficiently high to lead to the hybrid-
ization of the antisense RNA to its target. Analysis of core
protein expression in immortalized hepatocytes follow-
ing antisense core gene expression suggested 60–72%
reduction in core protein expression within day 2 and
remained at a similar level up to our study period of day
6. We observed previously that immortalized hepatocytes
express a weak level of core protein (Ray et al., 2000) as
compared to other mammalian cells expressing core
protein from transient transfection or infection with a
recombinant vaccinia virus. Results were very consistent
irrespective of whether monoclonal or polyclonal anti-
bodies were used for detection of core protein expres-
sion by Western blot or immunofluorescence study. We
estimate that the core protein expression level was at
least 25 times higher from a recombinant vaccinia virus
as compared to hepatocytes immortalized by introduc-
tion of the core gene when normalized with actin (un-
published data). Thus, our data with the immortalized
hepatocytes suggest that even though these cells ex-
press a low level of core protein, its inhibition to 60%
determines the threshold for apoptotic cell death. Hepa-
tocarcinogenesis involves alterations in the concerted
action of proto-oncogenes, growth factors, and tumor
suppressor genes. A variety of viral proteins immortalize
cells, suggesting that multiple mechanisms may lead to
an escape from senescence. We previously have re-
ported that HCV core protein regulates p53, p21, and
c-myc promoter activities based on the in vitro reporter
assays (Ray et al., 1997, 1998a). Here, we asked whether
HCV core protein expression in immortalized human
hepatocytes may indeed be associated with modulation
of these cellular genes. The p53 expression level in
immortalized hepatocytes was elevated upon expression
of the antisense core gene. HCV core protein constitu-
tively activates AP-1, which correlates with the activation
of JNK and MAPKK, known to regulate AP-1 (Shrivastava
et al., 1998). Premature senescence involving p53 is
activated in response to constitutive MEK/MAPK mito-
genic signaling (Lin et al., 1998). Thus, upregulation of
p53 expression and activation of procaspase-9 may con-
tribute to cell death in AS-core gene transfected hepato-
cytes. Therefore, our results suggest that a weak level of
core protein expression is detectable in immortalized
hepatocytes which is sufficient for maintenance of cell
growth and below which cells fail to survive.
A fundamental aspect of p53 is to participate in cell-
cycle checkpoint and apoptosis functions that regulate
homeostatic tissue renewal. This has been suggested
from a number of experimental observations. Exogenous
p53 expression can suppress the transformed pheno-
type of many cell types by inducing growth arrest and
apoptosis (Soddu and Sacchi, 1998). p53-deficient mice
have a highly penetrant tumor phenotype, with over 90%
tumor incidence within 9 months (Moll and Schramm,
1998). The modulation of p53 by viral proteins has been
observed and implicated in cell growth regulation. The
highly transformed properties of adenovirus E4 or E6 in
addition to E1A and E1B (Nevels et al., 1999a; Steegenga
et al., 1999) in cells correlate with a dramatic reduction of
p53 steady-state levels, which inversely correlates with
E4 or E6 expression (Nevels et al., 1999b). HTLV-1 Tax
protein has been shown to repress transcription of the
p53 gene, thus providing a possible mechanism by
which this viral protein contributes to transformation (Uit-
tenbogaard et al., 1995). SV40 large T antigen transforms
cells by sequestration and inactivation of p53 and reti-
noblastoma gene products. Thus, the absence of func-
tional p53 is expected to promote T-antigen mediated
tumorigenesis (Herzig et al., 1999), and a constant avail-
ability of T-antigen is necessary for maintenance of im-
mortalized human fibroblasts (Radna et al., 1989). The E6
and E7 gene products of HPV-16 and -18 can transform
human keratinocytes to an immortal or malignant phe-
notype. While the antisense RNA of E6 reduces cell
growth and lowers the ability to form colonies in soft
agar, the inhibition of E7 by antisense RNA causes cell
death after a lag period (Steele et al., 1992). HPV-16 E6
stimulates p53 protein degradation in mouse cells and
induces lymphomagenesis in a manner indistinguish-
able from p53 deficiency (Li et al., 1998). The loss of p53
function at an early stage of urothelial carcinogenesis
may result in acquisition of a malignant phenotype by
regulating cell cycle related genes (Okamoto et al., 1998).
Results from our study suggest a possible role of HCV
core protein mediated regulation of p53 gene expres-
sion, which may contribute to immortalization and growth
of primary human hepatocytes. Our results also suggest
that a threshold level of core protein might be necessary
for immortalization and maintenance of the immortalized
hepatocytes at an early stage, and 60% inhibition of
core protein expression in these immortalized hepato-
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cytes induces apoptotic cell death (Figs. 1, 2, and 3).
However, we cannot ascertain a threshold value for core
protein expression level in the absence of a standard
quantitative assay.
More than 85% of human cancers express telomerase
activity and a large proportion of human hepatocellular
carcinomas are telomerase positive (Tahara et al., 1995).
As the maintenance of telomeres is required for cells
to escape from replicative senescence and proliferate
indefinitely, immortalization of human cells requires
the reactivation of the telomere lengthening enzyme,
telomerase (Greider and Blackburn, 1985). HPV-16 E6
contributes to the immortalization of keratinocytes by
mediating the upregulation of hTERT and concomitant
activation of telomerase (Veldman et al., 2001). Our re-
sults suggested that core protein upregulates hTERT
promoter activity (Ray et al., 2000). The decrease in
telomere length upon antisense core gene expression in
immortalized hepatocytes also supports our results from
hTERT promoter activity. We also observed a reduction of
c-myc expression after introduction of the antisense core
gene. Since c-myc plays an important role in cell growth
regulation (Dang, 1999), it is likely that the lower level of
c-myc expression may contribute to the cell death pro-
cess. The mechanism of immortalization by HCV core
protein might result from a regulatory role in p53, hTERT,
and possibly c-myc overexpression leading to an alter-
ation in hepatocyte turnover. Signal transduction path-
ways are complex and interdependent. Thus, it is difficult
to conclude the exact mechanism of cell death. However,
our study highlights the modulation of these important
cell growth regulatory genes. Although the level of this
modulation is approximately twofold, these changes ap-
pear to have physiological relevance in cell growth reg-
ulation. At this time, the mechanism of core protein
mediated cellular gene regulation is not known. How-
ever, available information suggests that core protein
does not bind directly with cellular promoters and prob-
ably acts through unidentified cellular factors (Ray and
Ray, 2001). Thus, although HCV core protein expression
in primary human hepatocytes altered endogenous cell
growth regulatory gene expression, these changes can
be reversed by appropriate manipulation, such as intro-
duction of the antisense core gene. HCV core protein has
been observed to have a multifunctional activity similar
to that seen in a number of other viral proteins with
oncogenic potential. Moreover, the immortalization pro-
cess of primary human epithelial cells itself occurs
through a multistep process, and much of these steps
are not fully understood. Interestingly, antisense core
gene expression in late passage of the immortalized
hepatocytes (passage 50) did not exhibit cell death as
observed after early immortalization (passage 10) of cells
(Basu and Ray, unpublished observations). We have ob-
served that HCV core protein exhibits the ability to mod-
ulate a number of important cell cycle regulatory genes,
and these effects are altered following antisense core
gene expression after immortalization. Cross-talk among
cellular genes occurs during the process of immortaliza-
tion. However, to our knowledge, this is the first report
suggesting that HCV core protein may not only be asso-
ciated with the immortalization of human hepatocytes,
but is also required for the maintenance of this pheno-
typic change.
The effect of core protein from in vitro studies may
reflect an aggravated change in primary hepatocytes,
suggesting its transformation potential. Thus, in infected
liver, HCV core protein may stimulate cells to escape
from replicative senescence, giving rise to clonal prolif-
eration. For this, hepatocytes will need to overcome
different cell cycle control mechanisms. Further work
examining the mechanisms leading to deregulated ex-
pression of p53 or c-myc in chronically HCV infected
humans may provide understanding of the regulatory
pathways which, when defective, contribute to oncogen-
esis. Furthermore, targeted inhibition of core protein
function may offer new therapeutic modalities in HCV
mediated pathogenesis.
MATERIALS AND METHODS
Cells and plasmids
Primary human hepatocytes immortalized by transfec-
tion with the HCV core genomic region from genotype 1a
under the control of a CMV early promoter in pcDNA3
expression vector or under the control of MuLV LTR in
the pBabe-puro expression vector were generated as
described previously (Ray et al., 2000). Hepatocytes were
seeded on a collagen type I coated plate and maintained
at 37°C in a defined culture medium supplemented with
growth factors and antimicrobials (SAGM, Clonetics,
Walkersville, MD). The antisense orientation of the HCV
core gene (encoding amino acids 1–191) from the same
genotype 1a was cloned under the control of an induc-
ible metallothionein promoter in MTCB6 vector (kindly
provided by Frank J. Rauscher, III, Wistar Institute, Phil-
adelphia) or under the control of a MuLV LTR into pBabe-
puro vector.
Transfection and maintenance of hepatocytes
HCV core mediated immortalized hepatocytes (from
passage 10) were transfected with the antisense orien-
tation of the core gene (AS-core) or an empty vector
using lipofectamine. Briefly, cells were transfected with
an inducible promoter linked with antisense orientation
to HCV core gene or empty vector DNA (mock control).
After 48 h of transfection, cells were treated with G418
(800 g/ml), and resistant cells were selected and in-
duced with a predetermined dose of ZnCl2 (100 M) for
antisense core gene expression. There was no detect-
able growth inhibitory property of the immortalized hepa-
59HCV CORE PROTEIN AND IMMORTALIZATION OF HEPATOCYTES
tocytes at 100 M ZnCl2. Alternatively, cells transfected
with the antisense core gene cloned into pBabe-puro
vector were treated with puromycin (2 g/ml) for 4 days
and resistant colonies were pooled.
HCV core protein expression
The expression of HCV core protein in hepatocytes
was examined by Western blot analysis and flow cytom-
etry. Western blot analysis was performed (Ray et al.,
2000) using a rabbit antibody to HCV core protein (kindly
provided by Arvind Patel, University of Glasgow, En-
gland). An anti-rabbit immunoglobulin coupled with
horseradish was used as the second antibody to detect
core protein by chemiluminescence (ECL, Amersham).
Flow cytometric analysis was conducted using a specific
monoclonal antibody, O-17A, known to recognize epi-
topes between amino acid residues 80 and 160 (Virogen,
Watertown, MA) and an anti-mouse Ig conjugated to
fluorescein isothiocyanate (FITC) as a second antibody.
Hepatocytes (105) were fixed by treatment with 10%
formaldehyde. Fixed cells were incubated with 2% nor-
mal AB human serum (Sigma) in PBS for 15 min. Cells
were incubated with the monoclonal antibody O-17A in
PBS containing 4% FCS and 0.01% sodium azide, fol-
lowed by treatment with the second antibody conjugated
to FITC. After being washed, FITC stained cells were
analyzed by FACScan (Becton Dickinson) with Cell Quest
Version 3.2 software. Ten thousand cells were analyzed
for each sample and a gate was set on the basis of
dot plot for 90° light scatter versus forward angle light
scatter to exclude dead cells and debris from analysis.
Nonspecific background staining was determined with
mock transfected control cells treated only with the FITC
conjugated anti-mouse Ig.
Growth characteristics
Hepatocytes were plated in triplicate at a density of
105/ml and incubated with hepatocyte growth medium
containing ZnCl2 (100 M). Viable cells were counted
every 24 h by trypan blue exclusion.
Cellular gene expression
The same batch of cells used in FACS analysis was
examined for cellular gene expression to synchronize
the level of HCV core protein expression with cellular
gene expression. An RNase protection assay was per-
formed using custom-made probes (Pharmingen) to in-
vestigate the modulation of cellular genes as previously
described (Ray et al., 1989). Control human RNA provided
with the assay kit was used to ensure detection of
specific bands. Total cellular RNA was isolated from
mock transfected control or AS-core cells. RNA was
hybridized with radiolabeled custom-made antisense
RNA multiprobes (p53, p21, and L32). The reaction mix-
ture was digested with RNase A and RNase T1. The
protected fragments were analyzed by urea–polyacryl-
amide gel (5%) electrophoresis, followed by auto-
radiography. The autoradiogram was densitometrically
scanned to compare mRNA levels between control and
experimental cells after the values were normalized with
respect to the housekeeping gene, L32. Western blot
analysis was performed to analyze the expression levels
of p53, p21, Rb, and procaspase-9 proteins in control and
experimental cells using specific antibodies (Santa Cruz
Biotechnologies, Santa Cruz, CA). The level of c-myc
protein was also measured by Western blot analysis
using a specific monoclonal antibody (kindly provided by
Linda Penn, University of Toronto, Toronto, Ontario, Can-
ada). Briefly, equal amounts of proteins from whole-cell
lysates in sample buffer were separated by SDS–PAGE.
Proteins were transferred onto nitrocellulose, incubated
with specific antibodies, and detected by chemilumines-
cence (Amersham). Cellular actin was detected similarly
in the reprobed blot and used as an internal control for
relative quantitation of the proteins of interest in mock
control and AS-core transfected cells by densitometric
scanning.
Analysis for apoptotic cell death
Apoptotic cell death was analyzed from DNA fragmen-
tation by agarose gel electrophoresis as previously de-
scribed (Ray et al., 1996, 1998b). Additionally, the apopto-
tic response in hepatocytes was quantified from the
cytosolic oligonucleosome-bound DNA by a cell death
detection ELISA (Roche Diagnostics).
Telomerase and transient reporter gene assay
Telomerase activity was detected in cells early after
expression of the AS-core gene (between 5 and 6 days)
by a PCR-based telomerase-repeat amplification proto-
col as described previously (Ray et al., 2000). An in vitro
transient reporter assay was performed using an
800-bp regulatory region of hTERT linked with a lucif-
erase reporter gene (kindly provided by Riccardo Dalla-
Favera, Columbia University, New York) and effector plas-
mid DNAs. HepG2 or 293 cells were cotransfected with
the reporter gene construct, HCV core gene (CMVcore1–
191), and/or AS-core in pBabe-puro. Empty vector DNA
was used as a control for mock transfection. The total
amount of DNA was kept constant in the transfection
mixture by the addition of empty vector. Cells were har-
vested in the reporter lysis buffer (Promega, Madison,
WI) 48 h after transfection, and luciferase activity was
determined by a luminometer (Optocomp II, MGM Instru-
ments) as described previously (Ray et al., 1998a). The
luciferase activity was normalized with respect to protein
concentration in the cell lysates.
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